Skip to main content
Equibles
GOVX logo

GOVX · GeoVax Labs, Inc. · Webcasts, Transcripts & Audio

Track GOVX — free

Use GOVX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GOVX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.19 -0.01 (-5.63%)
Rebalance outlook locked
Going-concern doubt — flagged Jul 27, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors collectively raise substantial doubt about the Company’s ability to continue as a going concern. Management believes that we will be successful in securing the additional capital required to continue the Company’s planned operations, but that our plans do not fully alleviate the substantial doubt about the Company’s ability to operate as a going concern.”
View the 10-Q filed Jul 27, 2026
Market Cap
$1.52M
Shares
7.37M
Volume · Oct 26 226.45K Avg daily vol (3M) 762.64K

GeoVax Labs, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for GeoVax Labs, Inc. (GOVX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Capital Markets Day
Investor event
2026-05-28
GeoVax Labs, Inc. (GOVX) May 28, 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-13
GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript
Confident tone GEO-MVA Mpox/Smallpox vaccine and EMA expedited path Gedeptin oncology program and KEYNOTE-689 Partnering, collaboration and non-dilutive funding interest
Revenue
$0
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-28
GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript
Confident tone GEO-MVA mpox/smallpox vaccine GEO-CM04S1 COVID-19 vaccine for immunocompromised Gedeptin in head and neck cancer
Revenue
$852,282
▲ 183.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript
Positive tone GEO-CM04S1 COVID-19 vaccine for immunocompromised patients BARDA Project NextGen contract termination Gedeptin cancer therapy
Revenue
$1.64M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-28
GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call
Revenue
$864,415*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-13
GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript
Confident tone GEO-CM04S1 COVID-19 Vaccine BARDA Project NextGen Award Gedeptin Oncology Program
Revenue
$2.79M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call
Revenue
$300,677
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript
Positive tone CM04S1 COVID-19 vaccine Gedeptin Phase II head and neck cancer Immunocompromised patient focus
Revenue
$0
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-01
GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript
Positive tone Project NextGen / BARDA award Gedeptin (advanced head and neck cancer) GEO-CM04S1 COVID-19 vaccine (mRNA booster)
Revenue
$0*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript
Revenue
$0
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
GeoVax Labs, Inc. (GOVX) Q2 2023 Earnings Call Transcript
Revenue
$0
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-05
GeoVax Labs, Inc. (GOVX) Q1 2023 Earnings Call Transcript
Revenue
$0
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-24
GeoVax Labs, Inc. (GOVX) Q4 2022 Earnings Call Transcript
Revenue
$0*
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
GeoVax Labs, Inc. (GOVX) Q3 2022 Earnings Call Transcript
Revenue
$0
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
GeoVax Labs, Inc. (GOVX) Q2 2022 Earnings Call Transcript
Revenue
$0
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-02
GeoVax Labs, Inc. (GOVX) Q1 2022 Earnings Call Transcript
Revenue
$81,526
▼ 26.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
GeoVax Labs, Inc. (GOVX) Q4 2021 Earnings Call Transcript
Revenue
$164,962*
▼ 34.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
GeoVax Labs, Inc. (GOVX) Q3 2021 Earnings Call Transcript
Revenue
$30,414
▼ 92.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
GeoVax Labs, Inc. (GOVX) Q2 2021 Earnings Call Transcript
Revenue
$79,708
▼ 81.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-07
GeoVax Labs, Inc. (GOVX) Q1 2021 Earnings Call Transcript
Revenue
$110,417
▼ 84.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-23
GeoVax Labs, Inc. (GOVX) Q4 2020 Earnings Call Transcript
Revenue
$251,621*
▼ 6.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
GeoVax Labs, Inc. (GOVX) Q3 2020 Earnings Call Transcript
Revenue
$415,458
▲ 24.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 webcasts
Key facts CIK 832489 CUSIP 373678705 13F (30d) 2 filings 2 filers Visit website